TCL Archive DeVita Says Payline Compression Leading to More Decisions By Staff On Funding June 28, 1985
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003